WO2000020384A1 - Diphenyl compounds substituted by camphor or hydantoin derivatives as sunscreen compositions - Google Patents

Diphenyl compounds substituted by camphor or hydantoin derivatives as sunscreen compositions Download PDF

Info

Publication number
WO2000020384A1
WO2000020384A1 PCT/EP1999/006985 EP9906985W WO0020384A1 WO 2000020384 A1 WO2000020384 A1 WO 2000020384A1 EP 9906985 W EP9906985 W EP 9906985W WO 0020384 A1 WO0020384 A1 WO 0020384A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
camphor
products
hydrogen
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1999/006985
Other languages
English (en)
French (fr)
Inventor
Rudolf Zink
Dieter Reinehr
Helmut Luther
Bernd Herzog
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba Spezialitaetenchemie Holding AG
Ciba SC Holding AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Spezialitaetenchemie Holding AG, Ciba SC Holding AG filed Critical Ciba Spezialitaetenchemie Holding AG
Priority to DE69915658T priority Critical patent/DE69915658D1/de
Priority to EP99948810A priority patent/EP1117638B1/en
Priority to JP2000574502A priority patent/JP4471497B2/ja
Priority to US09/806,358 priority patent/US6384284B1/en
Priority to AU61939/99A priority patent/AU6193999A/en
Priority to BRPI9914250-3A priority patent/BR9914250B1/pt
Publication of WO2000020384A1 publication Critical patent/WO2000020384A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/24—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/683—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings having unsaturation outside the aromatic rings

Definitions

  • the present invention relates to diphenyl compounds, to a process for their preparation and to their use as light stabilisers.
  • Benzylidene camphors and their use as sunscreens in cosmetics are known, for example, from EP-A-0,693,471 and EP-A-0,370,867.
  • this invention relates to diphenyl compounds of formula
  • R is a camphor or hydantoin derivative
  • Ri is hydrogen; or CrCsalkyl.
  • CrC 5 Alkyl is straight-chain or branched aikyl radicals, such as methyl, ethyl, n-propyl, iso- propyl, n-butyl, sec-butyl, tert-butyl, amyl, isoamyl or tert-amyl.
  • Preferred diphenyl compounds are those of formula (1), wherein R is a radical of formulae
  • Y + is hydrogen; alkali metal; alkaline earth metal, Vz Zn , 1/3 Al , Vz Ba , ; and
  • R 2 , R 3 and R 4 are each independently of one another hydrogen; d-C 5 alkyl or hydroxy-Cr
  • Ri is hydrogen; or C ⁇ -C 5 alkyl; and Y + has the meaning given in formula (1).
  • the compounds of formula (1 ) are obtained, for example, by reacting a diphenylbisaldehyde of formula
  • R ! has the meaning given in formula (1 ), in the presence of a base or a Lewis acid with the corresponding camphor or hydantoin derivative.
  • the reaction is usually carried out in an inert diluent, preferably in a protic solvent, in particular an alcohol, such as methanol, ethanol, isopropanol or tert-butanol, or in an aprotic solvent, such as diethyl ether, toluene or cyclohexane, or in mixtures of the ted solvents.
  • a protic solvent in particular an alcohol, such as methanol, ethanol, isopropanol or tert-butanol
  • an aprotic solvent such as diethyl ether, toluene or cyclohexane, or in mixtures of the ted solvents.
  • the base is preferably an alkali alcoholate, such as sodium methylate, sodium ethylate or potassium tert-butylate.
  • the reaction can be carried out in the temperature range from 0°C to the boiling point of the reaction mixture, the preferred reaction temperature being in the range from 25 to 60°C.
  • camphor or hydantoin derivatives used as starting compounds are known compounds which are commercially available.
  • the compounds of formula (1 ) are particularly suitable as UV filters, i.e. for protecting ultraviolet-sensitive organic materials, especially human and animal skin and hair, from the harmful effect of UV radiation. These compounds are therefore suitable as light stabilisers in cosmetic, pharmaceutical and veterinary formulations.
  • the compounds can be used both in dissolved and in micronised state.
  • this invention relates to a cosmetic formulation comprising a compound of formula (1).
  • these light stabilisers - unless they are water-soluble - usually have an average particle size in the range from 0.02 to 2, preferably from 0.05 to 1.5, particularly preferably from 0.1 to 1.0 nm.
  • the insoluble light stabilisers of this invention can be brought to the desired particle size by conventional methods, for example by grinding using e.g. a nozzle mill, ball mill, vibratory or hammer mill.
  • Grinding is preferably carried out in the presence of 0.1 to 30, preferably of 0.5 to 15 % by weight, based on the UV absorber, of grinding aid, for example a vinyl pyrrolidone polymer, a vinyl pyrrolidone-vinyl acetate co- polymer, an acylglutamate, an alkylpolyglucoside or, preferably, a phospholipid.
  • grinding aid for example a vinyl pyrrolidone polymer, a vinyl pyrrolidone-vinyl acetate co- polymer, an acylglutamate, an alkylpolyglucoside or, preferably, a phospholipid.
  • the light stabilisers can also be used dry in powder form.
  • the light stabilisers are subjected to known grinding processes, such as vacuum atomisation, counter- current spray drying and the like. These powders have a particle size of 0.1 nm to 2 ⁇ m.
  • the light stabilisers can be coated prior to the pulverisation process with a surfactant, for example with an anionic, nonionic or amphoteric surfactant, e.g. phospholipids or known polymers, such as PVP, actylates etc.
  • the cosmetic formulation can also contain one or several UV protectives of the following substance classes.
  • p-Aminobenzoic acid derivatives such as 4-dimethylaminobenzoic acid-2-ethylhexyl ester
  • Salicylic acid derivatives such as salicylic acid-2-ethylhexyl ester
  • Benzophenone derivatives such as 2-hydroxy-4-methoxybenzophenone and its 5- sulfonic acid derivative
  • Dibenzoylmethane derivatives such as 1 -(4-tert-butylphenyl)-3-(4-methoxyphenyl)- propane-1 ,3-dione;
  • Diphenylacrylates such as 2-ethylhexyl-2-cyano-3,3-diphenylacrylate and 3-(benzofura- nyl)-2-cyanoacrylate; 6. 3-lmidazol-4-yl-acrylic acid and 3-imidazol-4-yl-acrylate;
  • Polymeric UV absorbers such as the benzylidenemalonate derivatives described, inter alia, in EP-A-709,080;
  • Cinnamic acid derivatives such as the 4-methoxycinnamic acid-2-ethylhexyl ester or isoamyl esters or cinnamic acid derivatives disclosed, inter alia, in US-A-5,601 ,811 and WO 97/00851 ;
  • Camphor derivatives such as 3-(4'-methyl)benzylideneboman-2-one, 3-benzylidene- bornan-2-one, N-[2(and 4)-2-oxyborn-3-ylidenemethyl)benzyl]acrylamide polymer, 3-(4'- trimethyl ammonium)benzylidenebornan-2-one methylsulfate, 3,3'-(1 ,4-phenylenedime- thine)bis(7,7-dimethyl-2-oxo-bicyclo-[2.2.1]heptane-1-methanesulfonic acid) and its salts, 3-(4'-sulfo)benzylideneboman-2-one and its salts;
  • Trianilino-s-triazine derivatives such as 2,4,6-trianiline-(p-carbo-2'-ethyl-1 '-oxi)-1 ,3,5- triazine and the UV absorbers disclosed in US-A-5,332,568, EP-A-517,104, EP-A-507,691 , WO 93/17002 and EP-A-570,838;
  • Inorganic micropigments such as TiO 2 (differently coated);
  • N-substituted benzimidazoles such as described in EP-A-0,843,995;
  • UV absorbers described in "Sunscreens", Eds. N.J. Lowe, N.A.Shaath, Marcel Dekker, Inc., New York and Basel or in Cosmetics & Toiletries (107), 50ff (1992) as additional UV protectives in the formulation of this invention.
  • the cosmetic formulations contain 0.1 to 15 % by weight, preferably 0.5 to 10 % by weight, based on the total weight of the formulation, of a light stabiliser of formula (1 ) or of a mixture of light stabilisers and a cosmetically compatible auxiliary.
  • the cosmetic formulations may be prepared by physically mixing the UV absorber(s) with the auxiliary by standard methods, for example by simply stirring the individual components together, preferably by exploiting the solubility characteristics of known cosmetic UV absorbers, such as OMC, isooctyl salicylate and others.
  • the cosmetic formulations can be formulated as water-in-oil or oil-in-water emulsion, as oil- in-alcohol lotion, as vesicular dispersion of a ionic or nonionic amphiphilic lipid, as gel, solid stick or as aerosol formulation.
  • the cosmetically compatible auxiliary preferably comprises 5 to 50% of an oil phase, 5 to 20% of an emulslfier and 30 to 90% of water.
  • the oil phase can in this case contain any oil suitable for cosmetic formulations, for example one or several hydrocarbon oils, wax, natural oil, silicone oil, fatty acid ester or fatty alcohol.
  • Preferred mono- or polyols are ethanol, isopropanol, propylene glycol, hexylene glycol, glycerol and sorbitol. It is also possible to use di- or/and trivalent metal salts (alkali earth metal, Al 3+ and others) of one or several alkylcarboxylic acids.
  • any conventionally usable emulsi- fier typically one or several ethoxylated esters of natural derivatives, such as polyethoxy- lated esters of hydrogenated castor oil; or silicone oil emulsifiers, such as silicone polyol; free or ethoxylated fatty acid soaps; fatty alcohol or fatty acid and their polyoxethylene derivatives; free or ethoxylated sorbitan esters; ethoxylated fatty acids or fatty acid esters; or ethoxylated glycerides.
  • ethoxylated esters of natural derivatives such as polyethoxy- lated esters of hydrogenated castor oil
  • silicone oil emulsifiers such as silicone polyol; free or ethoxylated fatty acid soaps; fatty alcohol or fatty acid and their polyoxethylene derivatives; free or ethoxylated sorbitan esters; ethoxylated fatty acids or fatty acid esters; or ethoxylated
  • emulsifiers are partial fatty acid esters of polyvalent alcohols, such as glycol, 1 ,2-propylene glycol, glycerol, sorbitol and pentaerythritol, and also protein-fatty acid condensates and lanolin derivatives, the salts of alkylcarboxylic acids, alkylsulfates or alkylsulfo- nates or polyglycol ethers. It is also possible to use mixtures of anion-active and nonionic emulsifiers or mixtures of purely nonionic surface-active substances having different HLB- values. Mixtures of fatty alcohol ethers and fatty acid polyglycol ethers or ethoxylated fats are also conventionally used.
  • the cosmetic formulations can also contain other components, for example emollients, emulsion stabilisers, skin moisturisers, suntan promoters, thickeners such as xanthan, moisture retention agents such as glycerol, preservatives, fragrances and colourants.
  • emollients for example emollients, emulsion stabilisers, skin moisturisers, suntan promoters, thickeners such as xanthan, moisture retention agents such as glycerol, preservatives, fragrances and colourants.
  • Cosmetic formulations of this invention include different cosmetic compositions.
  • Particularly suitable compositions are, for example, the following: skin-care products, for example skin washing and cleansing products in the form of bars of soap or liquid soaps, syndets or washing pastes, bath products, for example liquid (foam baths, milks, shower products) or solid bath products, such as bath pearls and bath salts; skin-care products, such as skin emulsions, multiple emulsions or skin oils; decorative body-care products, for example face make-ups In the form of day or powder creams, face powders (lose and compressed), rouge or cream make-ups, eye-care products, for example eye shadow products, mascara, eyeliners, eye creams or eye-fix creams; lip-care products, for example lipstick, lip gloss, lip liner, nail-care products, such as nail varnish, nail varnish remover, nail hardeners or cuticle removers; feminine hygiene products, such as feminine hygiene washing lotions or sprays; foot-care products, for example foot baths, foot powder
  • liquid formulations as W/O, O/W, O/W/O, W/O/W, PIT emulsions and all types of microemulsions
  • the cosmetic formulations are distinguished by excellent protection of the human skin against the harmful effect of sunlight.
  • camphor-10-sulfonic acid 23.3 g (+-) of camphor-10-sulfonic acid are dissolved in 100 ml of toluene and 5 ml of methanol at 25°C and are then charged with 11.2 g of sodium methylate and the mixture is heated, with stirring, to 66°C.
  • a circa 50°C warm solution consisting of 10.5 g of 1 ,1'-diphenyl-4,4'-bisaldehyde in 145 ml of toluene and 16 ml of methanol is then added to the above mixture over 2 hours at 66 to 70°C. This temperature is maintained for another 5 hours until no further increase of the product is found in a DC.
  • Toluene and methanol are then distilled off as an azeotrope while being charged successively with a total of 115 ml of water.
  • a solution forms at 98°C which is clarified by filtration using some carbon.
  • 300 ml of methanol are added dropwise and the mixture .is cooled to 10°C, the compound crystallising out as a sodium salt. After 2 hours, the precipitate is subjected to filtration and washed with 100 ml of methanol. Drying yields 16.8 g of crude product of the compound of formula
  • phase A and B are heated separately to 75-80°C and are gently combined. This is followed by intense homogenisation and cooling to room temperature with slight stirring. With stirring, D is admixed to the emulsion so obtained and is adjusted to pH 6.5 with E.
  • An in vitro SPF of 23 is determined by means of an Optometrics SPF-290 analyser (2 ⁇ l/cm 2 on Transpore film).
  • phase A and B are heated separately to 75-80°C and are slowly combined and homogenised. After cooling with slow stirring, the product is adjusted to pH 7.0 with E.
  • phase A and B are heated separately to 75-80°C and are gently combined. This is followed by intense homogenisation and cooling to room temperature with slight stirring. With stirring, phase D is admixed to the emulsion so obtained and the mixture is adjusted to pH 6.5 with phase E.
  • the oil phase and the water phase are heated separately to 75-80°C and are gently combined. This is followed by intense homogenisation and cooling to room temperature with slight stirring. With stirring, methylene bis-benzotriazolyl tetrametylbutylphenol is admixed to the emulsion so obtained.
  • the oil phase and the water phase are heated separately to 75-80°C and gently combined. This is followed by intense homogenisation and cooling to room temperature with slight stirring. With stirring, methylene bis-benzotriazolyl tetrametylbutylphenol is admixed to the emulsion so obtained.
  • the oil phase and the water phase are heated separately to 75-80°C and are gently combined. This is followed by intense homogenisation and cooling to room temperature with slight stirring.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PCT/EP1999/006985 1998-10-02 1999-09-21 Diphenyl compounds substituted by camphor or hydantoin derivatives as sunscreen compositions Ceased WO2000020384A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE69915658T DE69915658D1 (de) 1998-10-02 1999-09-21 Durch camphor- oder hydantoin-derivate substituierte diphenylverbindungen als lichtschutzmittel
EP99948810A EP1117638B1 (en) 1998-10-02 1999-09-21 Biphenyl compounds substituted by camphor or hydantoin derivatives as sunscreen compositions
JP2000574502A JP4471497B2 (ja) 1998-10-02 1999-09-21 日焼け止め組成物としてのショウノウ誘導体又はヒダントイン誘導体で置換されたジフェニル化合物
US09/806,358 US6384284B1 (en) 1998-10-02 1999-09-21 Biphenyl compounds substituted by camphor or hydantoin derivatives as sunscreen compositions
AU61939/99A AU6193999A (en) 1998-10-02 1999-09-21 Diphenyl compounds substituted by camphor or hydantoin derivatives as sunscreen compositions
BRPI9914250-3A BR9914250B1 (pt) 1998-10-02 1999-09-21 compostos de bifenila substituìdos por cánfora ou derivados de hidantoìna, processo de preparação dos referidos compostos, formulação cosmética contendo os mesmos e uso não terapêutico relacionado.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98810992 1998-10-02
EP98810992.2 1998-10-02

Publications (1)

Publication Number Publication Date
WO2000020384A1 true WO2000020384A1 (en) 2000-04-13

Family

ID=8236366

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/006985 Ceased WO2000020384A1 (en) 1998-10-02 1999-09-21 Diphenyl compounds substituted by camphor or hydantoin derivatives as sunscreen compositions

Country Status (10)

Country Link
US (1) US6384284B1 (cg-RX-API-DMAC10.html)
EP (1) EP1117638B1 (cg-RX-API-DMAC10.html)
JP (1) JP4471497B2 (cg-RX-API-DMAC10.html)
KR (1) KR100634215B1 (cg-RX-API-DMAC10.html)
CN (1) CN1264813C (cg-RX-API-DMAC10.html)
AU (1) AU6193999A (cg-RX-API-DMAC10.html)
BR (1) BR9914250B1 (cg-RX-API-DMAC10.html)
DE (1) DE69915658D1 (cg-RX-API-DMAC10.html)
ES (1) ES2216569T3 (cg-RX-API-DMAC10.html)
WO (1) WO2000020384A1 (cg-RX-API-DMAC10.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1213010A3 (de) * 2000-12-09 2004-03-24 Beiersdorf AG Verwendung von wasserlöslichen, filmbildenden Polymeren zur Verstärkung des Lichtschutzfaktors und/oder der UV-A-Schutzleistung kosmetischer oder dermatologischer Formulierungen
EP1145707A4 (en) * 1999-01-28 2005-08-31 Shiseido Co Ltd COMPOSITIONS FOR OUTSIDE USE
US7432400B2 (en) * 2001-09-07 2008-10-07 Ciba Specialty Chemicals Corp. Biphenylene compounds

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070238814A1 (en) * 2006-04-10 2007-10-11 Basf Corporation Method of making coating compositions
GB201607831D0 (en) * 2016-05-05 2016-06-22 Landa Labs 2012 Ltd UV protective compositions and their use

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2415819A1 (de) * 1974-04-01 1975-10-16 Basf Ag Azlactonfarbstoffe
DE3713094A1 (de) * 1986-04-22 1987-10-29 Ajinomoto Kk Benzylidenverbindungen und sie enthaltende kosmetische zubereitungen und ultraviolettabsorber
EP0370867A1 (fr) * 1988-11-22 1990-05-30 L'oreal Sels de métaux polyvalents de dérivés sulfonés du benzylidène-camphre et leur utilisation pour la protection de la peau contre le rayonnement ultraviolet
EP0693471A1 (de) * 1994-07-23 1996-01-24 MERCK PATENT GmbH Benzyliden-Norcampher-Derivate
DE4442324A1 (de) * 1994-11-29 1996-05-30 Merck Patent Gmbh Bis(methyliden)-phenylen-Derivate

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2415819A1 (de) * 1974-04-01 1975-10-16 Basf Ag Azlactonfarbstoffe
DE3713094A1 (de) * 1986-04-22 1987-10-29 Ajinomoto Kk Benzylidenverbindungen und sie enthaltende kosmetische zubereitungen und ultraviolettabsorber
EP0370867A1 (fr) * 1988-11-22 1990-05-30 L'oreal Sels de métaux polyvalents de dérivés sulfonés du benzylidène-camphre et leur utilisation pour la protection de la peau contre le rayonnement ultraviolet
EP0693471A1 (de) * 1994-07-23 1996-01-24 MERCK PATENT GmbH Benzyliden-Norcampher-Derivate
DE4442324A1 (de) * 1994-11-29 1996-05-30 Merck Patent Gmbh Bis(methyliden)-phenylen-Derivate

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1145707A4 (en) * 1999-01-28 2005-08-31 Shiseido Co Ltd COMPOSITIONS FOR OUTSIDE USE
EP1213010A3 (de) * 2000-12-09 2004-03-24 Beiersdorf AG Verwendung von wasserlöslichen, filmbildenden Polymeren zur Verstärkung des Lichtschutzfaktors und/oder der UV-A-Schutzleistung kosmetischer oder dermatologischer Formulierungen
US7432400B2 (en) * 2001-09-07 2008-10-07 Ciba Specialty Chemicals Corp. Biphenylene compounds

Also Published As

Publication number Publication date
EP1117638A1 (en) 2001-07-25
BR9914250A (pt) 2001-06-19
EP1117638B1 (en) 2004-03-17
CN1321145A (zh) 2001-11-07
JP4471497B2 (ja) 2010-06-02
ES2216569T3 (es) 2004-10-16
DE69915658D1 (de) 2004-04-22
US6384284B1 (en) 2002-05-07
BR9914250B1 (pt) 2012-08-21
JP2002526525A (ja) 2002-08-20
KR100634215B1 (ko) 2006-10-24
KR20010075554A (ko) 2001-08-09
CN1264813C (zh) 2006-07-19
AU6193999A (en) 2000-04-26

Similar Documents

Publication Publication Date Title
JP4252627B2 (ja) 対称トリアジン誘導体
KR101187002B1 (ko) 대칭 트리아진 유도체
JP4744754B2 (ja) ミクロ顔料からなる混合物
JP4344241B2 (ja) トリアジン誘導体、およびサンスクリーンとしてのその使用
KR101433142B1 (ko) 트리아진 유도체
KR101057747B1 (ko) 아미노 치환 히드록시페닐 벤조페논 유도체
MXPA06006409A (es) Derivados de merocianina para uso cosmetico.
EP1117641B1 (de) Indolinderivate als lichtschutzmittel
CN102448429B (zh) 亚苄基丙二酸酯
KR20070058518A (ko) 광안정성 화장품 또는 피부학적 조성물
EP1117638B1 (en) Biphenyl compounds substituted by camphor or hydantoin derivatives as sunscreen compositions
WO2001036396A1 (en) Use of benzotriazole uv absorbers
JP3611517B2 (ja) アミノアミジン誘導体を含有する光保護化粧品用組成物及びその用途
JPH092930A (ja) 光安定性の化粧品用光遮断組成物
CA2515320A1 (fr) Composes s-triazine possedant deux substituants choisis parmi des groupes para-aminobenzalmalonate et para-aminobenzalmalonamide encombres et un substituant aminobenzoate; compositions et utilisations

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99811708.0

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1999948810

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2000 574502

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 09806358

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1020017004214

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1999948810

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1020017004214

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 1999948810

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1020017004214

Country of ref document: KR